• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Springing Into the Latest Research in Dermatology

Dermatology TimesDermatology Times, April 2024 (Vol. 45. No. 04)
Volume 45
Issue 04

In an introduction to our April publication, explore an overview of topics covered in this issue and an introduction to our Spring Editor in Chief, Aaron Farberg, MD.

Medicine chemical research with organic in laboratory setting.
chokniti/Adobe Stock

The first quarter of the year is already over, and 2024 is off to a booming start in dermatology. Just last month, dermatology clinicians from across the globe gathered in San Diego, California, for the 2024 American Academy of Dermatology (AAD) Annual Meeting. Every AAD meeting is packed with hundreds of informative sessions led by experts in dermatology presenting the latest research.

In this issue, you will find highlights from numerous AAD sessions, including how to manage ichthyosis in a general dermatology office, surgical procedures to consider for hidradenitis suppurativa, tips for handling challenging interactions with patients, what dermatologists need to know about alopecia in 2024, and managing psoriasis with home phototherapy.

This month’s cover feature also sheds light on an AAD session focusing on benzene found in benzoyl peroxide (BPO)–containing acne products. Earlier in March, Valisure, an independent testing laboratory in Connecticut, found high levels of the International Agency for Research on Cancer group 1 carcinogen benzene in BPO products. At AAD 2024, Christopher Bunick, MD, PhD, presented the latest data related to the testing methods that Valisure used and the levels of benzene found at various incubating temperatures, beginning at room temperature. To stay up to date on the latest benzene news, be sure to visit dermatologytimes.com.

Dr Bunick, associate professor of dermatology and physician-scientist at the Yale School of Medicine in New Haven, Connecticut, also served as Dermatology Times’ winter editor in chief from January to March. Dermatology Times extends our sincerest gratitude to Dr Bunick and his contributions to and continued support of Dermatology Times.

We are also pleased to introduce our next editor in chief, Aaron Farberg, MD. Dr Farberg is a double board-certified dermatologist and fellowship-trained Mohs surgeon at Bare Dermatology in Dallas, Texas. Dermatology Times looks forward to Dr Farberg’s expertise over the next 3 months.

If you are looking to catch up on highlights from AAD or are interested in learning more from our video programs, subscribe to Dermatology Times e-newsletters to stay informed. Don’t forget to also follow us on social media and email us with ideas and feedback at DTEditor@mmhgroup.com.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.